医药:Results preview
1H23 Preview: expect weakness in-line; Back-end loaded in 2H23E
2022 preview: Continuing to enhance long-term growth logic
2Q23 preview: solid earnings growth despite social entertainment business adjustment
US Daily_ February Payrolls Preview (Hill)–20230312
1H23E preview: Expecting Strategy 2.0 to gain momentum in post-pandemic periods
–1H23E preview:new-car GPM could be a bottom
4Q preview: rev/np reach RMB30.7bn/1.1bn
–2Q23 preview: expecting strong recovery ahead
China Insurance Sector:FY21 results preview